Detalhe da pesquisa
1.
Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model.
J Clin Invest
; 134(11)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702076
2.
The human genetic variant rs6190 unveils Foxc1 and Arid5a as novel pro-metabolic targets of the glucocorticoid receptor in muscle.
bioRxiv
; 2024 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585940
3.
Glutaminase deficiency in rod photoreceptors disrupts nonessential amino acid levels to activate the integrated stress response and induce rapid degeneration.
bioRxiv
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586045
4.
Comprehensive Analyses of Muscle Function, Lean and Muscle Mass, and Myofiber Typing in Mice.
Bio Protoc
; 13(4): e4617, 2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845536
5.
Glucocorticoid intermittence coordinates rescue of energy and mass in aging-related sarcopenia through the myocyte-autonomous PGC1alpha-Lipin1 transactivation.
bioRxiv
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905062
6.
Light-phase prednisone promotes glucose oxidation in heart through novel transactivation targets of cardiomyocyte-specific GR and KLF15.
bioRxiv
; 2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187555
7.
Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids.
Mol Metab
; 62: 101528, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717025